27th December 2021 | Pharma Updates

India's Pharma Industry Response to the Covid Pandemic and Outlook for the Upcoming Year

Multiple therapies and vaccines were launched in years’ time, which never happened before the Covid pandemic.

Lupin gets a nod for Sevelamer Carbonate

The drug major has received approval from US FDA for Sevelamer Carbonate for Oral Suspension.

NIPER Raebareli Recruitment 2022

National Institute of Pharmaceutical Education and Research Raebareli has invited applications for Non-Teaching and Teaching posts.

Medtech, E-pharmacies to help slash health maintenance costs

Apart from vaccines, medicines and diagnostics, advancements in digital transformation, telemedicine, healthcare innovation and preventive care will be in the limelight in 2022.

Madurai Kamaraj University Researcher Develops Covid Diagnostic Kit In 12 Seconds

The diagnostic kit patented in India uses the same amount of the sample as an RT-PCR Test.

Cipla receives approval for Hydroxyurea

The pharma major is asked to submit post-marketing survey study protocol within 3 months of the approval of the drug.

Covaxin for Emergency Use In 12-18 yr old Kids

Covaxin is formulated in a unique way so that it can be given to kids and adults.